At the news
? BEARISHIMPACT 7/10 CLUSTER filed Mar 9, 2026 at 20:00 ET
BridgeBio Pharma CEO Kumar Neil sold shares worth over $1.6 million in open-market transactions, while Director Hannah Valantine exercised options and sold 8,671 shares for $624,312. The cluster is dominated by significant insider selling, with total open-market dispositions amounting to $2.27 million over seven days.
- CEO Kumar Neil sold 24,027 shares in two transactions totaling $1.64 million at prices between $68.36 and $68.48.
- Director Hannah Valantine exercised 8,671 options (intrinsic value $237,238.56) and sold all shares at $72 for $624,312 in proceeds.
- Total open-market sales in the cluster: $2.27 million.
- No open-market purchases or grants reported in the 7-day window.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access